IPBiz (Free subscription) | 07/23/2008
The CAFC affirmed the decision of SDNY in Eisai v. Dr. Reddy's and Teva, sending appellants Dr. Reddy's (represented by Budd Larner) and Teva (represented by Goodwin Procter) to the showers. The drug concerned was rabeprazole, which is part of a class of drugs known as proton pump inhibitors, which suppress gastric acid production by inhibiting action of the enzyme H+K+ATPase. The patent...
Seeking Alpha (Free subscription) | 07/23/2008
Aaron F. Barkoff submits: Eisai v. Dr. Reddy's and Teva , Nos. 2007-1397, -1398 (Fed. Cir. 2008) Patents on chemical compounds are holding up well to obviousness arguments in the Federal Circuit, even after KSR . In an opinion released Monday , the Federal Circuit affirmed the nonobviousness of rabeprazole, the active ingredient in Aciphex . This follows a decision last year affirming the nonobviousness...
Hindu (Free subscription) | 07/23/2008
Chennai girl Bindu Reddy wanted to see herself on the big screen some day. But the Biotechnology student from the Vellore Institute of Technology was just biding her time till she grew confident of facing the arc lights. So while she was doing ...
Hindu (Free subscription) | yesterday
CPI floor leader in Vijayawada Municipal Corporation general body P. Gowtham Reddy has asked the government to take necessary measures and help the family members of one-and-half year old boy, who died when a lorry overturned in Vambay colony. ...
Daily News Analysis (Free subscription) | 07/23/2008
Dr Reddy's Laboratories may have lost a $100 million profit opportunity with the US Court of Appeals for the Federal Circuit on Monday
Patent Docs (Free subscription) | 07/22/2008
By Kevin E. Noonan -- Sanity may be returning to the Federal Circuit's treatment of two issues, obviousness and inequitable conduct. In Eisai Co. v. Dr. Reddy's Laboratories, Inc., the Court (in an opinion by Judge Rader joined by Judges Linn and Proust) affirmed the District Court's determination that the patent-in-suit, U.S. Patent No. 5,045,552 was not obvious and was not obtained through...
The Telegraph India (Free subscription) | 07/21/2008
Mumbai, July 21: Dr Reddy's Laboratories (DRL) will buy out the stakes of Citigroup Venture Capital and ICICI Venture Funds Management Company in research and development firm Perlecan Pharma.
Daily News Analysis (Free subscription) | 07/22/2008
Dr Reddy's is set to take total control of Perlecan Pharma, the novel R&D model it had kicked off with funding support
Market Watch (Free subscription) | 07/21/2008
LONDON (MarketWatch) -- Indian generic drugmaker Dr. Reddy's Laboratories said Monday that net profit in its fiscal first quarter ending June 30 fell 28% to $31 million, or 19 cents a share, from $43 million, or 25 cents a share a year earlier. Revenue for the period rose 25% to $350 million under U.S. generally accepted accounting principles. The group said revenue growth was driven by its...
Hindu (Free subscription) | 07/21/2008
News: | | | | | | | | | | | | | | Advts: | | | Dr. Reddy’s Q1 net profit dips 26 p.c. Special Correspondent Revenues from global generic business go by25 per centPerlecan will become a wholly-owned subsidiaryof Dr. Reddy’s— PHOTO: SATISH H. KEY MARKETS DRIVE GROWTH: K. Satish Reddy (left), Managing Director, with G. V. Prasad, CEO, Dr. Reddy’s Laboratories, addressing a...
Hindu (Free subscription) | 07/21/2008
KadapaThulasi Reddy flays Left stand on nuclear deal Special Correspondent Calls their opposition a ‘historic mistake’ ‘India’s share in nuclear power was 2.72 p.c. compared to 79 p.c. in France’‘China entered into a nuclear deal with the US way back in 1985’KADAPA: The Left parties, which practiced outdated concepts, were opposing the Indo-US nuclear deal and other ‘opportunistic’ parties were...
India eNews: Top Headlines (Free subscription) | 07/21/2008
Mining and steel major Gala Janardhan Reddy (GJR) group has entered into a strategic alliance with PT Earthstone Resources of Indonesia to source iron ore from Sumatra mines for its greenfield integrated steel plant in Andhra Pradesh and export markets, said a top official here Monday.
Business Wire (Free subscription) | 07/21/2008
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (NYSE:RDY) today announced its unaudited financial results for the quarter ended June 30,
Hindu (Free subscription) | 07/20/2008
HYDERABAD: A three-and-a-half-hour daily power cut is being imposed to all the domestic and commercial consumers in Ranga Reddy(South), a press note from the Power authorities informed on Saturday. Following is the schedule announced by ...
Hindu (Free subscription) | 07/19/2008
HYDERABAD: All the domestic and commercial consumers in the Ranga Reddy circle (North) will have load reliefs as per the following schedule from July 19, a press note from the CPDCL informed on Friday. 8 a.m. to 11.30 ...
